- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01870336
Combination of Lateral Foot Orthoses and Knee Brace for Treatment of the Knee Osteoarthritis
March 3, 2016 updated by: Laval University
Combination of Lateral Foot Orthoses and Knee Brace for Treatment of the Medial Knee Osteoarthritis
The purpose of this study is to evaluate the immediate and short-term effects of the combination of lateral customized foot orthoses on the pain and medial knee loading during gait among medial knee osteoarthritis patients.
The effects of the combination is compared to the single use of these devices.
The investigators recruited 22 knee osteoarthritis.
They have to wear each of treatments (foot orthoses, knee brace and combination) during three months.
A fifteen days wash-out period is given after each three months.
Biomechanical evaluation is carried out before and after each three months.
This evaluation consisted of three questionnaires (Knee Osteoarthritis Outcome Score (KOOS), Western Ontario and McMaster Universities Osteoarthritis Index ( WOMAC) and Medical Outcome Study Short Form-36( MOS-SF36)), a motion analysis with an optoelectronic system, then a 6-min walk test.
During motion analysis, ten gait trials are executed without treatment and ten with the treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1V 0A6
- Pavillon de l'Éducation Physique et des Sports - Université Laval
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Symptomatic medial knee OA (Kellgren-Lawrence grade I, II or III) according to clinical and radiological criteria of the American College of Rheumatology
- Knee pain > 31/100 (Western Ontario and McMaster Universities Arthritis Index - WOMAC)
- Moderately active
- Varus knee alignment equal or superior to 2°
Exclusion Criteria:
- Severe knee OA (K-L grade IV)
- Rheumatoid arthritis or other inflammatory arthritis
- Avascular necrosis
- History of periarticular fracture or septic arthritis
- Bone metabolic disease
- Pigmented villonodular synovitis
- Cartilaginous disease
- Neuropathic arthropathy
- Synovial osteochondromatosis
- Total or partial knee arthroplasty
- Flexion contracture of ipsi- or contra-lateral knee greater than 15°
- Hip or ankle joint damage with mobility limitation
- Obesity (BMI ≥ 40)
- Intra-articular corticosteroids injection in the affected knee during the two previous months
- Reduced mobility (Charnley class C)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Lateral customized foot orthoses
Foot orthoses with arch support and lateral inclination set at 7° (alone)
|
|
EXPERIMENTAL: Knee brace
OdrA Knee brace (alone)
|
|
EXPERIMENTAL: Combination of the two treatments
Combination of Lateral customized foot orthoses and knee brace
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Knee adduction moment
Time Frame: Change from Baseline at 3 months
|
Change from Baseline at 3 months
|
|
Change in Knee pain
Time Frame: Change from Baseline at 3 months
|
A 20-cm visual analog scale (0-100) is used to assess pain.
|
Change from Baseline at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Knee adduction angle
Time Frame: Change from Baseline at 3 months
|
Change from Baseline at 3 months
|
|
Change in Spatiotemporal gait parameters
Time Frame: Change from Baseline at 3 months
|
Change from Baseline at 3 months
|
|
Change in Comfort
Time Frame: Change from Baseline at 3 months
|
A 20-cm visual analog scale (0-100) is used to assess comfort.
|
Change from Baseline at 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (ACTUAL)
May 1, 2014
Study Completion (ACTUAL)
May 1, 2014
Study Registration Dates
First Submitted
May 23, 2013
First Submitted That Met QC Criteria
June 3, 2013
First Posted (ESTIMATE)
June 6, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 4, 2016
Last Update Submitted That Met QC Criteria
March 3, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OC-2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on Combined treatment of medial knee osteoarthritis
-
Joint AcademyLund UniversityCompletedOsteoarthritis, Knee | Osteoarthritis, HipSweden
-
Organon and CoCompleted
-
Lund UniversityCompletedKnee Osteoarthritis | Hip OsteoarthritisSweden
-
Assiut UniversityNot yet recruitingOsteoarthritis, Knee
-
Baylor College of MedicineM.D. Anderson Cancer Center; Agency for Healthcare Research and Quality (AHRQ)Completed
-
Iacob Czihac Emergency Military Clinical HospitalCompleted
-
Marmara UniversityCompletedKnee Osteoarthritis | Hip OsteoarthritisTurkey
-
The S.N. Fyodorov Eye Microsurgery State InstitutionUnknownRhegmatogenous Retinal DetachmentRussian Federation
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Dr.Saqib Hussain AnsariUnknownThalassemia, BetaPakistan